Senior insider sale
Chief Executive Officer at RAPPORT THERAPEUTICS, INC. — senior position signals high conviction
$5.48M
130.73K shares
CEESAY ABRAHAM plans to sell 130.73K shares of RAPPORT THERAPEUTICS, INC. valued at approximately $5.48M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Acquired as compensation -- Performance Awards
Compensation
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/2/2022 | Acquired as compensation -- Performance Awards Compensation | 39.47K | — |
| Total | 39.47K | ||
Completed
Units to sell
2.21K
Market value
$86.6K
Units to sell
2.21K
Market value
$99.9K
Units to sell
6K
Market value
$274.6K
Units to sell
6K
Market value
$297.2K
Units to sell
4.42K
Market value
$218.0K
Units to sell
8.50K
Market value
$422.8K
Units to sell
28.96K
Market value
$1.39M
Units to sell
22.54K
Market value
$1.04M
Units to sell
2.21K
Market value
$93.1K
Units to sell
6K
Market value
$241.2K
Units to sell
2.21K
Market value
$87.2K
Planned — Approximate Date
Units to sell
39.47K
Market value
$1.23M
Units
130.73K
Value
$5.48M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/23/2026 | 2.21K | $86.6K | — | Completed |
9/8/2026 | 2.21K | $99.9K | — | Completed |
9/8/2026 | 6K | $274.6K | — | Completed |
8/25/2026 | 6K | $297.2K | — | Completed |
8/25/2026 | 4.42K | $218.0K | — | Completed |
8/25/2026 | 8.50K | $422.8K | — | Completed |
8/11/2026 | 28.96K | $1.39M | — | Completed |
8/10/2026 | 22.54K | $1.04M | — | Completed |
7/27/2026 | 2.21K | $93.1K | — | Completed |
7/14/2026 | 6K | $241.2K | — | Completed |
7/14/2026 | 2.21K | $87.2K | — | Completed |
| Planned — Approximate Date | ||||
10/6/2026 | 39.47K | $1.23M | NASD | Planned |
| Total | 130.73K | $5.48M | ||